Survey of quality of life for patients with breast ductal carcinoma in situ and analysis of related factors
10.3760/cma.j.issn.1673-422X.2013.02.022
- VernacularTitle:乳腺导管原位癌患者生活质量调查及相关因素分析
- Author:
Beiqi JIANG
;
Yun FU
;
Yi WU
;
Xiaolin CHENG
;
Zhengdong LI
;
Zhigang ZHUANG
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Carcinoma;
intraductal,noninfiltrating;
Quality of life;
SF-36
- From:
Journal of International Oncology
2013;(2):153-156
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the quality of life (QOL) of patients with ductal carcinoma in situ (DCIS) and to analyze the relevant factors affecting their QOL.Methods A total of 84 patients with DCIS and 125 patients with invasive breast cancer were surveyed.Researchers used SF-36 to assess the QOL of participants at one year after operation.The relationships between some information of patients and SF-36 score were analyzed,such as age,the type of surgery,endocrine therapy,education,marital status,working status and health insurance.Results Compared to normal women,patients with DCIS had lower QOL in physical function (t =2.468,P =0.029),bodily pain (t =2.076,P =0.039),general health (t =2.153,P =0.033) and mental health (t =3.396,P =0.003).Patients with invasive breast cancer also had poorer QOL in physical function (t =5.638,P =0.002),bodily pain (t =5.417,P =0.002),vitality (t =4.438,P =0.002),general health (t =3.960,P =0.002) and mental health (t =6.020,P =0.001).QOL of DCIS patients was similar to that of invasive breast cancer patients,except that scores of physical function (t =2.714,P =0.032) and vitality (t =2.134,P =0.040) were better in DCIS patients.Endocrine therapy significantly affected the score of QOL of DCIS patients.DCIS patients with endocrine therapy had poorer score in physical function (t =2.082,P < 0.05),bodily pain (t =2.003,P < 0.05),general health (t =2.751,P <0.05),vitality (t =2.048,P < 0.05) and mental health (t =4.162,P < 0.05).Conclusion Patients with DCIS have poor QOL at one year after operation.Endocrine therapy significantly reduces their QOL.